Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-48671

Single-particle
2.2 Å
EMD-48671
3D View Gallery
Deposition: 16/01/2025
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48671
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9mvu summary report (pdf.gz) Map and 9mvu FULL report (pdf.gz)
EMICSS annotations (xml)

C6 Herpes Virus Simplex Neutralizing Nanobody Bound to HSV Glycoprotein gB

EMD-48671

Single-particle
2.2 Å
EMD-48671
3D View Gallery
Deposition: 16/01/2025
Map released: 13/08/2025
Last modified: 13/08/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Human herpesvirus 1 (strain 17)
Sample: One C6 Neutralizing Nanobody bound to each monomer of the HSV Glycoprotein B Trimer
Fitted models: 9mvu

Deposition Authors: Viadiu H, Abernathy E, Lee CV, Hung M, Yu Y, Xing W, Yu X
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease.
Lee CV, Viadiu H, Kalamkar A, Bernstein DI, Pae A, Yu X, Wong S, Bravo FJ, Ding S, Seto E, Hung M, Yu Y, Xing W, Papalia GA, Kan W, Carr B, Thomas M, Tong L, Desai P, Jarrousse N, Mercier A, Holdorf MM, Fletcher SP, Abernathy E
(2025) Cell Rep , 44 , 116063 - 116063
PUBMED: 40716063
DOI: doi:10.1016/j.celrep.2025.116063
ISSN: 2211-1247
Grant Support: